Broker recommendations for Aphria
The Aphria, Inc. stock is rated at 1.083333 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Wednesday 16 September, 2020 by a total of 12 brokers. This means that the consensus of the 12 different brokers is leaning toward to buy.
Sell
0 (0%) Underweight
0 (0%) Hold
1 (8.33%) Overweight
0 (0%) Buy
11 (91.67%)
Price target by analysts
The 11 latest analyst estimates, per Friday 18 September, 2020, show the following high, low and average price targets.
Target Average: 6.73 USD
Target High: 9.36 USD
Target Low: 5.24 USD
Better Marijuana Stock: Aphria vs. Aurora Cannabis | The Motley Fool
Saturday, 19 September 2020, 13:30:00
Both of these big names have had their fair share of stumbles. But one is showing glimmers of hope.
— The Motley Fool
2 Cannabis Stocks to Buy Amid the Current Challenging Environment
Wednesday, 16 September 2020, 22:00:17
Given their strong balance sheets and a viable business models, Aphria and Canopy Growth are well equipped to ride out this challenging period. The post 2 Cannabis Stocks to Buy Amid the Current Challenging Environment appeared first on The Motley Fool Canada .
— The Motley Fool Canada
‘Psyched’: Havn Life Goes Public, CannaGlobal Inks Merger, Numinus Raises CA$4.6M
Friday, 11 September 2020, 23:01:18
Havn Life Goes Public on CSE and Announces Authorization for Research Havn Life Sciences Inc . (CSE : HAVN ), a recently-formed psychedelics company, announced on Tuesday its debut on the Canadian Securities Exchange under the symbol HAVN. The company is led by co-CEOs Susan Chapelle and Tim Moore, the former CEO of cannabis company Green Growth Brands Inc. Other supporters include Vic Neufeld , former CEO of Aphria (NASDAQ: APHA ), who serves as director of the board. The board also includes Canada’s former deputy prime minister Sheila Copps. Formed in June of 2020, Havn defines itself as a biotechnology company focused on “unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi.” The company operates a research facility located in the South Campus at The University of British Columbia. “We are currently working on … Full story available on Benzinga.com
— Benzinga
VIDEO — Ex-Aphria Boss Vic Neufeld Joins Psychedelics Industry
Friday, 11 September 2020, 01:30:26
Vic Neufeld, ex-CEO of Canadian cannabis producer Aphria, is back — and this time he’s joining the rising psychedelics industry. The post VIDEO — Ex-Aphria Boss Vic Neufeld Joins Psychedelics Industry appeared first on Investing News Network .
— Investing News Network
1 Weed Stock IPO on the TSX Is a Low-Key Millionaire Maker
Tuesday, 8 September 2020, 19:00:03
Here’s why Aphria (TSX:APHA)(NASDAQ:APHA) stock has strong long-term prospects given its huge market presence and low valuation multiple. The post 1 Weed Stock IPO on the TSX Is a Low-Key Millionaire Maker appeared first on The Motley Fool Canada .
— The Motley Fool Canada
